vs
Side-by-side financial comparison of INSTEEL INDUSTRIES INC (IIIN) and Protagonist Therapeutics, Inc (PTGX). Click either name above to swap in a different company.
Protagonist Therapeutics, Inc is the larger business by last-quarter revenue ($170.6M vs $159.9M, roughly 1.1× INSTEEL INDUSTRIES INC). Protagonist Therapeutics, Inc runs the higher net margin — 77.2% vs 4.7%, a 72.4% gap on every dollar of revenue. On growth, Protagonist Therapeutics, Inc posted the faster year-over-year revenue change (184.4% vs 23.3%). Protagonist Therapeutics, Inc produced more free cash flow last quarter ($182.8M vs $-2.2M).
Insteel Industries Inc is a leading U.S. manufacturer of steel reinforcing products including welded wire reinforcement and steel fibers. It primarily serves non-residential construction, infrastructure, and precast concrete segments across North America, delivering high-performance reinforcement solutions for various construction projects.
Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel peptide-based targeted therapies for unmet medical needs, primarily covering gastrointestinal disorders, inflammatory diseases and rare disease indications. Its lead product candidates target inflammatory bowel disease and other chronic immune-related conditions, with operations spanning global R&D and partnership collaborations.
IIIN vs PTGX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2024
| Metric | | |
|---|---|---|
| Revenue | $159.9M | $170.6M |
| Net Profit | $7.6M | $131.7M |
| Gross Margin | 11.3% | — |
| Operating Margin | 6.0% | 74.3% |
| Net Margin | 4.7% | 77.2% |
| Revenue YoY | 23.3% | 184.4% |
| Net Profit YoY | 602.4% | 381.7% |
| EPS (diluted) | $0.39 | $2.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $159.9M | — | ||
| Q3 25 | $177.4M | — | ||
| Q2 25 | $179.9M | — | ||
| Q1 25 | $160.7M | — | ||
| Q4 24 | $129.7M | $170.6M | ||
| Q3 24 | $134.3M | — | ||
| Q2 24 | $145.8M | — | ||
| Q1 24 | $127.4M | $255.0M |
| Q4 25 | $7.6M | — | ||
| Q3 25 | $14.6M | — | ||
| Q2 25 | $15.2M | — | ||
| Q1 25 | $10.2M | — | ||
| Q4 24 | $1.1M | $131.7M | ||
| Q3 24 | $4.7M | — | ||
| Q2 24 | $6.6M | — | ||
| Q1 24 | $6.9M | $207.3M |
| Q4 25 | 11.3% | — | ||
| Q3 25 | 16.1% | — | ||
| Q2 25 | 17.1% | — | ||
| Q1 25 | 15.3% | — | ||
| Q4 24 | 7.3% | — | ||
| Q3 24 | 9.1% | — | ||
| Q2 24 | 10.6% | — | ||
| Q1 24 | 12.3% | — |
| Q4 25 | 6.0% | — | ||
| Q3 25 | 10.8% | — | ||
| Q2 25 | 11.0% | — | ||
| Q1 25 | 8.3% | — | ||
| Q4 24 | 1.1% | 74.3% | ||
| Q3 24 | 4.5% | — | ||
| Q2 24 | 6.0% | — | ||
| Q1 24 | 7.0% | 80.9% |
| Q4 25 | 4.7% | — | ||
| Q3 25 | 8.2% | — | ||
| Q2 25 | 8.4% | — | ||
| Q1 25 | 6.4% | — | ||
| Q4 24 | 0.8% | 77.2% | ||
| Q3 24 | 3.5% | — | ||
| Q2 24 | 4.5% | — | ||
| Q1 24 | 5.4% | 81.3% |
| Q4 25 | $0.39 | — | ||
| Q3 25 | $0.74 | — | ||
| Q2 25 | $0.78 | — | ||
| Q1 25 | $0.52 | — | ||
| Q4 24 | $0.06 | $2.01 | ||
| Q3 24 | $0.24 | — | ||
| Q2 24 | $0.34 | — | ||
| Q1 24 | $0.35 | $3.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.6M | $418.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $358.8M | $675.3M |
| Total Assets | $456.1M | $744.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $15.6M | — | ||
| Q3 25 | $38.6M | — | ||
| Q2 25 | $53.7M | — | ||
| Q1 25 | $28.4M | — | ||
| Q4 24 | $36.0M | $418.9M | ||
| Q3 24 | $111.5M | — | ||
| Q2 24 | $97.7M | — | ||
| Q1 24 | $83.9M | $322.6M |
| Q4 25 | $358.8M | — | ||
| Q3 25 | $371.5M | — | ||
| Q2 25 | $356.2M | — | ||
| Q1 25 | $341.4M | — | ||
| Q4 24 | $331.6M | $675.3M | ||
| Q3 24 | $350.9M | — | ||
| Q2 24 | $346.0M | — | ||
| Q1 24 | $340.6M | $560.4M |
| Q4 25 | $456.1M | — | ||
| Q3 25 | $462.6M | — | ||
| Q2 25 | $471.9M | — | ||
| Q1 25 | $421.9M | — | ||
| Q4 24 | $404.7M | $744.7M | ||
| Q3 24 | $422.6M | — | ||
| Q2 24 | $414.6M | — | ||
| Q1 24 | $397.2M | $629.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-701.0K | $184.2M |
| Free Cash FlowOCF − Capex | $-2.2M | $182.8M |
| FCF MarginFCF / Revenue | -1.4% | 107.1% |
| Capex IntensityCapex / Revenue | 0.9% | 0.8% |
| Cash ConversionOCF / Net Profit | -0.09× | 1.40× |
| TTM Free Cash FlowTrailing 4 quarters | $439.0K | $101.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-701.0K | — | ||
| Q3 25 | $-17.0M | — | ||
| Q2 25 | $28.5M | — | ||
| Q1 25 | $-3.3M | — | ||
| Q4 24 | $19.0M | $184.2M | ||
| Q3 24 | $16.2M | — | ||
| Q2 24 | $18.8M | — | ||
| Q1 24 | $1.4M | $-27.4M |
| Q4 25 | $-2.2M | — | ||
| Q3 25 | $-18.7M | — | ||
| Q2 25 | $26.9M | — | ||
| Q1 25 | $-5.5M | — | ||
| Q4 24 | $16.3M | $182.8M | ||
| Q3 24 | $14.5M | — | ||
| Q2 24 | $15.5M | — | ||
| Q1 24 | $-580.0K | $-27.7M |
| Q4 25 | -1.4% | — | ||
| Q3 25 | -10.6% | — | ||
| Q2 25 | 15.0% | — | ||
| Q1 25 | -3.5% | — | ||
| Q4 24 | 12.6% | 107.1% | ||
| Q3 24 | 10.8% | — | ||
| Q2 24 | 10.7% | — | ||
| Q1 24 | -0.5% | -10.9% |
| Q4 25 | 0.9% | — | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 1.4% | — | ||
| Q4 24 | 2.1% | 0.8% | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 2.2% | — | ||
| Q1 24 | 1.5% | 0.1% |
| Q4 25 | -0.09× | — | ||
| Q3 25 | -1.17× | — | ||
| Q2 25 | 1.88× | — | ||
| Q1 25 | -0.32× | — | ||
| Q4 24 | 17.56× | 1.40× | ||
| Q3 24 | 3.48× | — | ||
| Q2 24 | 2.86× | — | ||
| Q1 24 | 0.20× | -0.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IIIN
| Welded Wire Reinforcement | $108.4M | 68% |
| PC Strand | $51.6M | 32% |
PTGX
Segment breakdown not available.
